1. An update on emerging therapeutic options for the treatment of trigeminal neuralgia. (2nd November 2017) Authors: Obermann, Mark; Katsarava, Zaza; Holle, Dagny Journal: Expert opinion on orphan drugs Issue: Volume 5:Number 11(2017:Nov.) Page Start: 859 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An update on the management of post-traumatic headache. (November 2015) Authors: Obermann, Mark; Naegel, Steffen; Bosche, Bert; Holle, Dagny Journal: Therapeutic advances in neurological disorders Issue: Volume 8:Number 6(2015:Nov.) Page Start: 311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial. Issue 1 (December 2015) Authors: Burmeister, Jan; Holle, Dagny; Bock, Eva; Ose, Claudia; Diener, Hans-Christoph; Obermann, Mark Journal: Trials Issue: Volume 16:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cluster headache and the hypothalamus: causal relationship or epiphenomenon?. (September 2011) Authors: Holle, Dagny; Obermann, Mark Journal: Expert review of neurotherapeutics Issue: Volume 11:Number 9(2011) Page Start: 1255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Erenumab for migraine prevention in a patient with mitochondrial encephalopathy, lactate acidosis, and stroke‐like episodes syndrome: A case report. Issue 4 (29th March 2021) Authors: Naegel, Steffen; Burow, Philipp; Holle, Dagny; Stoevesandt, Dietrich; Heintz, Simon; Thaele, Annemarie; Zierz, Stephan; Kraya, Torsten Journal: Headache Issue: Volume 61:Issue 4(2021) Page Start: 694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Hypnic headache and caffeine. (September 2012) Authors: Holle, Dagny; Obermann, Mark Journal: Expert review of neurotherapeutics Issue: Volume 12:Number 9(2012) Page Start: 1125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Hypnic headache. (December 2013) Authors: Holle, Dagny; Naegel, Steffen; Obermann, Mark Journal: Cephalalgia Issue: Volume 33:Number 16(2013) Page Start: 1349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Hypnic headache. (September 2010) Authors: Obermann, Mark; Holle, Dagny Journal: Expert review of neurotherapeutics Issue: Volume 10:Number 9(2010) Page Start: 1391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impaired wound healing in a migraine patient as a possible side effect of calcitonin gene-related peptide receptor antibody treatment: A case report. (October 2020) Authors: Wurthmann, Sebastian; Nägel, Steffen; Hadaschik, Eva; Schlott, Swantje; Scheffler, Armin; Kleinschnitz, Christoph; Holle, Dagny Journal: Cephalalgia Issue: Volume 40:Number 11(2020) Page Start: 1255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Integrated multidisciplinary care of headache disorders: A narrative review. (October 2016) Authors: Gaul, Charly; Liesering-Latta, Eva; Schäfer, Benjamin; Fritsche, Günther; Holle, Dagny Journal: Cephalalgia Issue: Volume 36:Number 12(2016) Page Start: 1181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗